Search
Now showing items 1-9 of 9
Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival.
(International journal of cancer, 2019-02-08)
Fatty acids play a key role in cellular bioenergetics, membrane biosynthesis and intracellular
signaling processes and thus may be involved in cancer development and progression.
In the present study, we comprehensively ...
Genetic Variants in RUNX3, AMD1 and MSRA in the Methionine Metabolic Pathway and Survival in Non-small Cell Lung Cancer Patients.
(International journal of cancer, 2019-01-16)
Abnormal methionine dependence in cancer cells has led to methionine restriction as
a potential therapeutic strategy. We hypothesized that genetic variants involved in
methionine-metabolic genes are associated with survival ...
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.
(Lancet Neurol, 2015-08)
BACKGROUND: A systematic assessment of potential disease-modifying compounds for Parkinson's
disease concluded that pioglitazone could hold promise for the treatment of patients
with this disease. We assessed the effect ...
A prognostic model of Alzheimer's disease relying on multiple longitudinal measures and time-to-event data.
(Alzheimer's & dementia : the journal of the Alzheimer's Association, 2018-05)
INTRODUCTION:Characterizing progression in Alzheimer's disease is critically important
for early detection and targeted treatment. The objective was to develop a prognostic
model, based on multivariate longitudinal markers, ...
Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival.
(International journal of cancer, 2019-04)
The complement system plays an important role in the innate and adaptive immunity,
complement components mediate tumor cytolysis of antibody-based immunotherapy, and
complement activation in the tumor microenvironment may ...
Genetic variants in the liver kinase B1-AMP-activated protein kinase pathway genes and pancreatic cancer risk.
(Molecular carcinogenesis, 2019-04-17)
The liver kinase B1-AMP-activated protein kinase (LKB1-AMPK) pathway has been identified
as a new target for cancer therapy, because it controls the glucose and lipid metabolism
in response to alterations in nutrients and ...
Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
(Annals of surgical oncology, 2019-06-17)
BACKGROUND:Although the National Comprehensive Cancer Network (NCCN) guidelines recommend
use of lymph node dissection (LND) in patients with pancreatic neuroendocrine tumors
(pNETs) > 2 cm, there is limited evidence to ...
Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk.
(Cancer science, 2019-06)
Pancreatic cancer (PanC) is one of the most lethal solid malignancies, and metastatic
PanC is often present at the time of diagnosis. Although several high- and low-penetrance
genes have been implicated in PanC, their roles ...
Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large-scale analysis of 14 published GWAS datasets in the DRIVE study.
(International journal of cancer, 2019-09)
A recent hypothesis-free pathway-level analysis of genome-wide association study (GWAS)
datasets suggested that the overall genetic variation measured by single nucleotide
polymorphisms (SNPs) in the nucleotide excision ...